146 related articles for article (PubMed ID: 3117445)
21. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
[TBL] [Abstract][Full Text] [Related]
22. Induction of ovulation and pregnancy with HU-FSH (Metrodin) in women with polycystic ovarian disease: summary of clinical experience.
Venturoli S; Fabbri R; Paradisi R; Magrini O; Porcu E; De Tomasi F; Flamigni C
Acta Eur Fertil; 1983; 14(1):29-34. PubMed ID: 6426231
[TBL] [Abstract][Full Text] [Related]
23. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
24. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
25. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
[TBL] [Abstract][Full Text] [Related]
26. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
[TBL] [Abstract][Full Text] [Related]
27. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
Sagle MA; Hamilton-Fairley D; Kiddy DS; Franks S
Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
[TBL] [Abstract][Full Text] [Related]
28. Hypothalmic-pituitary relationships in the polycystic ovary syndrome serum gonadotrophin levels following injection of oestradiol benzoate.
Shaw RW; Duignan NM; Butt WR; Edwards RL; London DR
Br J Obstet Gynaecol; 1975 Dec; 82(12):952-7. PubMed ID: 1106757
[TBL] [Abstract][Full Text] [Related]
29. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone.
Shoham Z; Patel A; Jacobs HS
Fertil Steril; 1991 Jun; 55(6):1051-6. PubMed ID: 1903725
[TBL] [Abstract][Full Text] [Related]
30. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.
Prelevic GM; Ginsburg J; Maletic D; Hardiman P; Okolo S; Balint-Peric L; Thomas M; Orskov H
Hum Reprod; 1995 Jan; 10(1):28-32. PubMed ID: 7745065
[TBL] [Abstract][Full Text] [Related]
31. Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease.
Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
Int J Gynaecol Obstet; 1989 Feb; 28(2):163-9. PubMed ID: 2563704
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of ovulation induction.
Wu CH
Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
[TBL] [Abstract][Full Text] [Related]
33. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone.
Kamrava MM; Seibel MM; Berger MJ; Thompson I; Taymor ML
Fertil Steril; 1982 Apr; 37(4):520-3. PubMed ID: 6802679
[TBL] [Abstract][Full Text] [Related]
34. Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience.
Paulson RJ; Sauer MV; Lobo RA
J Assist Reprod Genet; 1994 Jan; 11(1):28-32. PubMed ID: 7949832
[TBL] [Abstract][Full Text] [Related]
35. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
36. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
Venturoli S; Orsini LF; Paradisi R; Fabbri R; Porcu E; Magrini O; Flamigni C
Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
[TBL] [Abstract][Full Text] [Related]
37. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
Saffan D; Seibel MM
Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
[TBL] [Abstract][Full Text] [Related]
38. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
[TBL] [Abstract][Full Text] [Related]
39. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
[TBL] [Abstract][Full Text] [Related]
40. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
Yarali H; Bukulmez O; Gurgan T
Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
